A&G PHARMACEUTICAL, INC.

DBA: PRECISISON ANTIBODY

COLUMBIA, MARYLAND 210452006

$201K
Total Contract Value
33 awards
First Award
May 25, 2022
Last Award
Sep 25, 2025
Business Size
other than small
CAGE Code
1T9L5

Top Industries (NAICS)

NAICS CodeObligationsAwards
541715$155K12
541380$19K1
325414$17K3
325998$14K1
325412$-1,6398
541714$-9,3632
541690$-12,5481

Contract Awards

17 awards found

75N95C25P00114
Department of Health and Human Services
$14K
Sep 25, 2025

TO GENERATE REAGENTS AGAINST AZM-152, A DRUG CANDIDATE FROM TDB AZOME PROJECT.

NAICS: 325998 - ALL OTHER MISCELLANEOUS CHEMICAL PRODUCT AND PREPARATION MANUFACTURINGFY2025
75N93025P00729
Department of Health and Human Services
$17K
Mar 24, 2025

MONOCLONAL ANTIBODY AGAINST MARCH1 PREPARATION MAB-P3-00-001, 002, 003, 005 AND MAB-P3-HC-001 (AMBIS #2254762)

NAICS: 325414 - BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURINGFY2025
75N91020P00499
Department of Health and Human Services
$-5,603.75
Feb 14, 2025

TO DE-OBLIGATE FUNDS FROM FY2020 EXPIRING LINES FOLLOWING NIH OALM COMMUNICATION 25-06 (20241105).

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025
75N93024P01059
Department of Health and Human Services
$19K
Aug 27, 2024

PRECISION ANTIBODY (AMBIS #2229539) LAB TESTING, FUSION, CLONING

NAICS: 541380 - TESTING LABORATORIES AND SERVICESFY2024
75N91019P00615
Department of Health and Human Services
$-12,548
Aug 12, 2024

TO DE-OBLIGATE FUNDS FROM FY2019 EXPIRING LINES IN ACCORDANCE WITH NIH OALM COMMUNICATION

NAICS: 541690 - OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICESFY2024
75N95022F00001
Department of Health and Human Services
$37K
Jul 11, 2024

POLYCLONAL RAT ANTIBODY AND MONOCLONAL RAT ANTIBODIES AGAINST GLYCOL-CHITOSAN NANOPARTICLES

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75N95019F00088
Department of Health and Human Services
$-54,639.25
May 29, 2024

GENERATING DRUG SPECIFIC MONOCLONAL ANTIBODIES AGAINST TTHX1114, AN ENGINEERED MUTANT HUMAN FGF1: GENERATING DRUG SPECIFIC MONOCLONAL ANTIBODIES AGAINST TTHX1114, AN ENGINEERED MUTANT HUMAN FGF1, TASK ORDER NO. 1 UNDER THE PARENT IDIQ, REAGENT GENERA

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75N93019P01122
Department of Health and Human Services
$-14,786
May 15, 2024

MONOCLONAL ANTIBODY PRODUCTION OF PVS230

NAICS: 325414 - BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURINGFY2024
75N95D19P00216
Department of Health and Human Services
$-787
Apr 4, 2024

MONOCLONAL ANTIBODY (MAB) DEVELOPMENT

NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURINGFY2024
75N95D19P00219
Department of Health and Human Services
$-852
Apr 3, 2024

PEPTIDE SYNTHESIS

NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURINGFY2024
75N95024F00001
Department of Health and Human Services
$106K
Mar 13, 2024

TASK ORDER 7 - DOK7

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75N95023F00001
Department of Health and Human Services
$16K
Feb 21, 2024

TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75N95023F00001
Department of Health and Human Services
$116K
Aug 31, 2023

TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
75N95021F00002
Department of Health and Human Services
$-69,056.88
Aug 2, 2023

CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
12913519P0021
Department of Agriculture
$-3,759.25
Dec 14, 2022

PEPT001 ANTIBODY DEVELOPMENT - PEPTIDE SYNTHESIS PER AMINO ACID. PEPTIDE #1 AND #2 SEQUENCE.

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75N93022P01267
Department of Health and Human Services
$15K
Sep 23, 2022

CUSTOM MONOCLONAL ANTIBODIES

NAICS: 325414 - BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURINGFY2022
75N95021F00001
Department of Health and Human Services
$3K
May 25, 2022

GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST PTH-IA.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2022

Business Details

UEI
SN6SWFABJXL1
CAGE Code
1T9L5
Address
9130 RED BRANCH RD STE X
COLUMBIA, MD 210452006
Congressional District
MD-03

Parent Company

A&G PHARMACEUTICAL, INC.

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov